Meningitis is the inflammation of the spinal and brain cord membrane caused by bacterial or viral infection. Viral infection is most commonly caused by a virus such as enteroviruses, mumps virus, and herpes simplex virus.
Meningitis is the inflammation of the spinal and brain cord membrane caused by bacterial or viral infection. Viral infection is most commonly caused by a virus such as enteroviruses, mumps virus, and herpes simplex virus. Bacterial infection is rare but can be fatal if not treated, and is caused by bacteria such as Haemophilus influenzae type b (Hib) bacteria, pneumococcal bacteria, and meningococcal bacteria. According to an article published on 30th September 2021 in BMC, about 1.2 million bacterial meningitis cases are estimated globally every year in Africa.
Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39794
The infection has emerged to be a global concern due to its long-term consequences and death rates that have the potential to cause an epidemic. The government is providing active support to establish sophisticated meningitis diagnostic test methods and treatment options to eradicate the disease. For instance, National Center for Disease Control provides referral diagnoses for various infectious diseases such as meningitis, malaria, and tuberculosis among others that are not available in medical colleges and hospitals. Thus, government initiatives to support meningitis diagnostic tests are anticipated to boost market growth during the forecast period.
Furthermore, the rising prevalence of HIV/AIDS and infectious diseases are expanding the growth prospects of meningitis diagnostic tests. According to WHO in 2021, about 1.5 million people were diagnosed with HIV and 6,50,000 people died due to HIV & related diseases. In addition, according to CDC in 2019, 7.2 million people visited physicians with parasitic and infectious diseases and 3.4 million people visited the emergency department for the diagnosis of infectious diseases.
Moreover, growing technological advancements and increasing healthcare sector developments are driving market growth. For instance, in July 2022, Abacus Diagnostica launched a CE-marked GenomEra PCR assay kit to aid healthcare professionals in the diagnosis of the four most cost common viruses causing infection, in 70 minutes. This PCR kit avoids the use of unnecessary antibiotics and helps start proper treatment immediately. Similarly, in 2020 BioFire Diagnostics launched the FilmArray ME panel in Taiwan designed to detect 14 pathogens that cause disease frequently and was approved for reimbursement in 2021. Such technological advancements are increasing the accuracy of meningitis diagnostic tests at early stages and are expected to boost market growth.
The market is segmented by test type, end-user, and region. The type segment includes latex agglutination tests, lateral flow assay, PCR assay, ELISA tests, culture test, and others. The end-user segment includes hospitals, diagnostic centers, and others.
Key Drivers
- Rise in demand for point-of-care services is anticipated to drive the meningitis diagnostic testing market in EMEA during the forecast period. Point-of-care services provide more accurate results in less time compared to traditional methods.
- New, innovative technologies such PCR and next-generation sequencing are available in the market, providing a less expensive way for the diagnosis, prognosis, and therapy selection in patients during their treatment. This helps physicians frame appropriate therapeutic systems for patients suffering from the infectious disease.
- In May 2018, BioGX B.V. launched Six CE-Mark tests for meningitis and antibiotic resistance. Meningitis test includes viral meningitis HSV/VZV, bacterial meningitis NSH, and bacterial meningitis ELGBS.
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39794
Increasing Healthcare Expenditure to Drive Market Growth in North America
The meningitis diagnosis and treatment market in North America region held the largest market share in the year 2021 as a result of sound development in healthcare sector, and large scale adoption of advanced diagnostic devices. As per the World Bank, healthcare expenditure, considering the total percentage of the GDP in the region, increased from 16.23% in 2018 to 16.32% in 2019. In addition to this, the rising number of medical devices companies in the region, and their increasing number of product launches are predicted to fuel market growth over the projected years. The US Medical device industry in 2023 is anticipated to be worth USD 210 billion. The export value of the medical device industry in the US was worth almost USD 45 billion in 2018.
Upsurge in Incidences of Meningitis to Favor Market Growth in the Middle East & Africa Region
On the other hand, the market in the Middle East & Africa region is estimated to witness generous growth by growing at a modest CAGR over the forecast period. The market growth can be majorly attributed to the prevalence of meningitis cases and growing need for advanced diagnostics. As per the Centers for Disease Control and Prevention (CDC), the sub-Saharan Africa is known as the ‘meningitis belt’ of the world owing to high risks of the disease. In every 5-12 years, 1000 cases per 100000 populations is reported during the occurrence of major epidemic of meningococcal meningitis in the region.
Key Players
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- ELITechGroup
- BioFire Diagnostics
- Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers
- Seegene, Inc.
- Luminex Corporation
- Qnostics Ltd.
- IMMY
- others
Market Segmentation
- By Test Type
- Latex Agglutination Tests
- Lateral Flow Assay
- PCR Assay
- ELISA Tests
- Culture Test
- Others
- By End-user
- Hospitals
- Diagnostic Centers
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Top of Form
Click Here to View Full Report Table of Contents
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39794
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://qyresearchmedical.com/